Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
1 other identifier
interventional
796
1 country
95
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of various fixed daily doses of WC3055 compared with placebo for the treatment of subjects with LUTS secondary to BPH.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Aug 2013
Shorter than P25 for phase_2
95 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 4, 2013
CompletedFirst Posted
Study publicly available on registry
September 11, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedJune 29, 2015
June 1, 2015
7 months
September 4, 2013
June 1, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Total IPSS (International Prostate Symptom Score)
Sum of Questions 1-7.
Final Visit (Week 12 or final visit)
Secondary Outcomes (6)
Change from Baseline Total IPSS
Week 4
Change from Baseline Total IPSS
Week 8
Change from Baseline IIEF-EF (International Index of Erectile Function-Erectile Function) Domain Score
Week 4
Change from Baseline IIEF-EF Domain Score
Week 8
Change from Baseline IIEF-EF Domain Score
Week 12
- +1 more secondary outcomes
Study Arms (5)
WC3055-01F
EXPERIMENTALWC3055 12.5 mg tablet once daily for 12 weeks
WC3055-02F
EXPERIMENTALWC3055 25 mg tablet once daily for 12 weeks
WC3055-03F
EXPERIMENTALWC3055 50 mg tablet once daily for 12 weeks
WC3055-04F
EXPERIMENTALWC3055 75 mg tablet once daily for 12 weeks
WC3055-07P
PLACEBO COMPARATORPlacebo tablet once daily for 12 weeks
Interventions
Eligibility Criteria
You may qualify if:
- History of LUTS for ≥6 months secondary to BPH
- Total IPSS (International Prostate Symptom Score) ≥ 13 at Screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Warner Chilcottlead
Study Sites (95)
Warner Chilcott Investigational Study Site
Homewood, Alabama, 35209, United States
Warner Chilcott Investigational Study Site
Huntsville, Alabama, 35801, United States
Warner Chilcott Investigational Study Site
Mobile, Alabama, 36608, United States
Warner Chilcott Investigational Study Site
Chandler, Arizona, 85224, United States
Warner Chilcott Investigational Study Site
Gilbert, Arizona, 85295, United States
Warner Chilcott Investigational Study Site
Glendale, Arizona, 85306, United States
Warner Chilcott Investigational Study Site
Phoenix, Arizona, 85032, United States
Warner Chilcott Investigational Study Site
Laguna Hills, California, 92653, United States
Warner Chilcott Investigational Study Site
Murrieta, California, 92562, United States
Warner Chilcott Investigational Study Site
San Diego, California, 92103, United States
Warner Chilcott Investigational Study Site
San Diego, California, 92108, United States
Warner Chilcott Investigational Study Site
San Diego, California, 92120, United States
Warner Chilcott Investigational Study Site
San Diego, California, 92123, United States
Warner Chilcott Investigational Study Site
Colorado Springs, Colorado, 80922, United States
Warner Chilcott Investigational Study Site
Denver, Colorado, 80211, United States
Warner Chilcott Investigational Study Site
Denver, Colorado, 80220, United States
Warner Chilcott Investigational Study Site
Denver, Colorado, 80239, United States
Warner Chilcott Investigational Study Site
Englewood, Colorado, 80113, United States
Warner Chilcott Investigational Study Site
Parker, Colorado, 80134, United States
Warner Chilcott Investigational Study Site
Middlebury, Connecticut, 06762, United States
Warner Chilcott Investigational Study Site
New Britain, Connecticut, 06052, United States
Warner Chilcott Investigational Study Site
Aventura, Florida, 33180, United States
Warner Chilcott Investigational Study Site
Clearwater, Florida, 33756, United States
Warner Chilcottt Investigational Study Site
Clearwater, Florida, 33761, United States
Warner Chilcott Investigational Study Site
Hialeah, Florida, 33016, United States
Warner Chilcott Investigational Study Site
Jacksonville, Florida, 32207, United States
Warner Chilcott Investigational Study Site
Kissimmee, Florida, 34741, United States
Warner Chilcott Investigational Study Site
Miami, Florida, 33136, United States
Warner Chilcott Investigational Study Site
Miami, Florida, 33173, United States
Warner Chilcott Investigational Study Site
Ocala, Florida, 34471, United States
Warner Chilcott Investigational Study Site
Pembroke Pines, Florida, 33028, United States
Warner Chilcott Investigational Study Site
Tallahassee, Florida, 32308, United States
Warner Chilcott Investigational Study Site
Atlanta, Georgia, 30342, United States
Warner Chilcott Investigational Study Site
Sandy Springs, Georgia, 30328, United States
Warner Chilcott Investigational Study Site
Coeur d'Alene, Idaho, 83864, United States
Warner Chilcott Investigational Study Site
Chicago, Illinois, 60654, United States
Warner Chilcott Investigational Study Site
Evanston, Illinois, 60201, United States
Warner Chilcott Investigational Study Site
Melrose Park, Illinois, 60160, United States
Warner Chilcott Investigational Study Site
Springfield, Illinois, 62703, United States
Warner Chilcott Investigational Study Site
Springfield, Illinois, 62794, United States
Warner Chilcott Investigational Study Site
Anderson, Indiana, 46011, United States
Warner Chilcott Investigational Study Site
Fort Wayne, Indiana, 46825, United States
Warner Chilcott Investigational Study Site
Jeffersonville, Indiana, 47130, United States
Warner Chilcott Investigational Study Site
Muncie, Indiana, 47304, United States
Warner Chilcott Investigational Study Site
Newburgh, Indiana, 47630, United States
Warner Chilcott Investigational Study Site
West Des Moines, Iowa, 50266, United States
Warner Chilcott Investigational Study Site
Overland Park, Kansas, 66202, United States
Warner Chilcott Investigational Study Site
Shreveport, Louisiana, 71106, United States
Warner Chilcott Investigational Study Site
Elkridge, Maryland, 21075, United States
Warner Chilcott Investigational Study Site
Glen Burnie, Maryland, 21061, United States
Warner Chilcott Investigational Study Site
Owing Mills, Maryland, 21117, United States
Warner Chilcott Investigational Study Site
Towson, Maryland, 21204, United States
Warner Chilcott Investigational Study Site
Brookline, Massachusetts, 02445, United States
Warner Chilcott Investigational Study Site
Omaha, Nebraska, 68114, United States
Warner Chilcott Investigational Study Site
Las Vegas, Nevada, 85282, United States
Warner Chilcott Investigational Study Site
Lawrenceville, New Jersey, 08648, United States
Warner Chilcott Investigational Study Site
Albuquerque, New Mexico, 87109, United States
Warner Chilcott Investigational Study Site
Albany, New York, 12208, United States
Warner Chilcott Investigational Study Site
Brooklyn, New York, 11206, United States
Warner Chilcott Investigational Study Site
Garden City, New York, 11530, United States
Warner Chilcott Investigational Study Site
Great Neck, New York, 11021, United States
Warner Chilcott Investigational Study Site
Kingston, New York, 12401, United States
Warner Chilcott Investigational Study Site
New York, New York, 10016, United States
Warner Chilcott Investigational Study Site
Newburgh, New York, 12550, United States
Warner Chilcott Investigational Study Site
Poughkeepsie, New York, 12601, United States
Warner Chilcott Investigational Study Site
Cary, North Carolina, 27518, United States
Warner Chilcott Investigational Study Site
Charlotte, North Carolina, 28210, United States
Warner Chilcott Investigational Study Site
Concord, North Carolina, 28025, United States
Warner Chilcott Investigational Study Site
High Point, North Carolina, 27262, United States
Warner Chilcott Investigational Study Site
Raleigh, North Carolina, 27609, United States
Warner Chilcott Investigational Study Site
Raleigh, North Carolina, 27612, United States
Warner Chilcott Investigational Study Site
Salisbury, North Carolina, 28144, United States
Warner Chilcott Investigational Study Site
Wilmington, North Carolina, 28401, United States
Warner Chilcott Investigational Study Site
Winston-Salem, North Carolina, 27103, United States
Warner Chilcott Investigational Study Site
Cincinnati, Ohio, 45212, United States
Warner Chilcott Investigational Study Site
Cincinnati, Ohio, 45215, United States
Warner Chilcott Investigational Study Site
Cincinnati, Ohio, 45249, United States
Warner Chilcott Investigational Study Site
Columbus, Ohio, 31904, United States
Warner Chilcott Investigational Study Site
Columbus, Ohio, 43212, United States
Warner Chilcott Investigational Study Site
Lyndhurst, Ohio, 44124, United States
Warner Chilcott Investigational Study Site
Bala-Cynwyd, Pennsylvania, 19004, United States
Warner Chilcott Investigational Study Site
Lancaster, Pennsylvania, 17604, United States
Warner Chilcott Investigational Study Site
Reading, Pennsylvania, 19609, United States
Warner Chilcott Investigational Study Site
Warwick, Rhode Island, 02886, United States
Warner Chilcott Investigational Study Site
Charleston, South Carolina, 29407, United States
Warner Chilcott Investigational Study Site
Myrtle Beach, South Carolina, 29572, United States
Warner Chilcott Investigational Study Site
Bristol, Tennessee, 37620, United States
Warner Chilcott Investigational Study Site
Austin, Texas, 78756, United States
Warner Chilcott Investigational Study Site
Dallas, Texas, 75234, United States
Warner Chilcott Investigational Study Site
San Antonio, Texas, 78229, United States
Warner Chilcott Investigational Study Site
Salt Lake City, Utah, 84107, United States
Warner Chilcott Investigational Study Site
Virginia Beach, Virginia, 23462, United States
Warner Chilcott Investigational Study Site
Winchester, Virginia, 22601, United States
Warner Chilcott Investigational Study Site
Mountlake Terrace, Washington, 98043, United States
Warner Chilcott Investigational Study Site
Wauwatosa, Wisconsin, 53226, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Herman Ellman, MD
Warner Chilcott
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2013
First Posted
September 11, 2013
Study Start
August 1, 2013
Primary Completion
March 1, 2014
Study Completion
April 1, 2014
Last Updated
June 29, 2015
Record last verified: 2015-06